A pilot study discovered that the FSHR Ser680Asn genotype does not influence the follicular fluid hormonal profile or ovulation outcomes in cycles stimulated with varying gonadotropin preparations. The research, involving 40 women undergoing ART, compared two genetic variants and determined no significant impact on treatment results.
Read More
Mason Greenwood Nears Exit from Manchester United Amid Transfer Negotiations
UEFA Euro 2024 Quarterfinal Showdown: Spain vs. Germany Predictions and Odds
Victor Boniface Escapes Major Injury in Serious Car Accident Confirmed by Bayer Leverkusen
Japanese Prime Minister Fumio Kishida to Resign Amidst Political Turmoil and Scandals
Liverpool vs Brighton Match Preview: Clash at Anfield and What to Expect
